Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Organogenesis Holdings (ORGO) Long-Term Debt Issuances (2018 - 2020)

Organogenesis Holdings has reported Long-Term Debt Issuances over the past 3 years, most recently at $10.0 million for Q1 2020.

  • Quarterly results put Long-Term Debt Issuances at $10.0 million for Q1 2020, down 75.0% from a year ago — trailing twelve months through Dec 2020 was $10.0 million (down 80.0% YoY), and the annual figure for FY2021 was $73.2 million, up 631.74%.
  • Long-Term Debt Issuances for Q1 2020 was $10.0 million at Organogenesis Holdings, roughly flat from $10.0 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for ORGO hit a ceiling of $40.0 million in Q1 2019 and a floor of -$5.0 million in Q2 2018.
  • Median Long-Term Debt Issuances over the past 3 years was $10.0 million (2019), compared with a mean of $13.8 million.
  • Peak annual rise in Long-Term Debt Issuances hit 75.0% in 2020, while the deepest fall reached 75.0% in 2020.
  • Organogenesis Holdings' Long-Term Debt Issuances stood at -$5.0 million in 2018, then soared by 300.0% to $10.0 million in 2019, then changed by 0.0% to $10.0 million in 2020.
  • The last three reported values for Long-Term Debt Issuances were $10.0 million (Q1 2020), $10.0 million (Q3 2019), and $40.0 million (Q1 2019) per Business Quant data.